These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 7822521)
1. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521 [TBL] [Abstract][Full Text] [Related]
2. Cyclosporin versus etretinate: Italian multicenter comparative trial in severe plaque-form psoriasis. Italian Multicenter Study Group on Cyclosporin in Psoriasis. Dermatology; 1993; 187 Suppl 1():8-18. PubMed ID: 8369579 [TBL] [Abstract][Full Text] [Related]
3. Remission of ordinary psoriasis following a short clearance course of cyclosporin. Levell NJ; Shuster S; Munro CS; Friedmann PS Acta Derm Venereol; 1995 Jan; 75(1):65-9. PubMed ID: 7747540 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports). Kokelj F; Plozzer C; Torsello P; Trevisan G J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):177-9. PubMed ID: 9784049 [TBL] [Abstract][Full Text] [Related]
5. Topical anthralin therapy for refractory nail psoriasis. Yamamoto T; Katayama I; Nishioka K J Dermatol; 1998 Apr; 25(4):231-3. PubMed ID: 9609979 [TBL] [Abstract][Full Text] [Related]
6. Acitretin : A Review of its Pharmacology and Therapeutic Use. Pilkington T; Brogden RN Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 28421560 [TBL] [Abstract][Full Text] [Related]
7. Short- and long-term considerations concerning the management of plaque psoriasis with low-dose cyclosporin. Studio Italiano Multicentrico nella Psoriasi (SIMPSO). Dermatology; 1993; 187 Suppl 1():19-29. PubMed ID: 8369576 [TBL] [Abstract][Full Text] [Related]
8. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting. van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study. Gümüşel M; Özdemir M; Mevlitoğlu I; Bodur S J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1080-4. PubMed ID: 21118309 [TBL] [Abstract][Full Text] [Related]
10. A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis. Schopf RE; Langendorf Y; Benz RE; Färber L; Benes P J Invest Dermatol; 2002 Jul; 119(1):160-5. PubMed ID: 12164939 [TBL] [Abstract][Full Text] [Related]
11. Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study. Gottlieb SL; Heftler NS; Gilleaudeau P; Johnson R; Vallat VP; Wolfe J; Gottlieb AB; Krueger JG J Am Acad Dermatol; 1995 Oct; 33(4):637-45. PubMed ID: 7545705 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of cyclosporine and etretinate on serum cytokine levels in patients with psoriasis. Shiohara T; Imanishi K; Sagawa Y; Nagashima M J Am Acad Dermatol; 1992 Oct; 27(4):568-74. PubMed ID: 1401309 [TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of psoriasis vulgaris treatments: analysis of treatment with topical corticosteroid and/or vitamin D3 analog, oral cyclosporin, etretinate and phototherapy over a 35-year period, 1975-2010. Akasaka E; Mabuchi T; Manabe Y; Yahagi E; Yamada-Hiruma A; Yamaoka H; Kojima T; Kato M; Ikoma N; Ozawa A; Haruki Y J Dermatol; 2013 Apr; 40(4):238-43. PubMed ID: 23330814 [TBL] [Abstract][Full Text] [Related]
14. [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis]. Gajardo J Rev Med Chil; 1989 May; 117(5):516-22. PubMed ID: 2519162 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients. Faerber L; Braeutigam M; Weidinger G; Mrowietz U; Christophers E; Schulze HJ; Mahrle G; Meffert H; Drechsler S Am J Clin Dermatol; 2001; 2(1):41-7. PubMed ID: 11702620 [TBL] [Abstract][Full Text] [Related]
16. Interventions for nail psoriasis. de Vries AC; Bogaards NA; Hooft L; Velema M; Pasch M; Lebwohl M; Spuls PI Cochrane Database Syst Rev; 2013 Jan; (1):CD007633. PubMed ID: 23440816 [TBL] [Abstract][Full Text] [Related]
17. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid. Swinkels OQ; Prins M; Kucharekova M; de Boo T; Gerritsen MJ; van der Valk PG; van de Kerkhof PC Br J Dermatol; 2002 Apr; 146(4):621-6. PubMed ID: 11966693 [TBL] [Abstract][Full Text] [Related]
18. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study. Gollnick H; Bauer R; Brindley C; Orfanos CE; Plewig G; Wokalek H; Hoting E J Am Acad Dermatol; 1988 Sep; 19(3):458-68. PubMed ID: 2971692 [TBL] [Abstract][Full Text] [Related]
19. Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis. Schopf RE; Höcher J; Rehder M; Färber L; Morsches B Arch Dermatol Res; 1992; 284(4):227-31. PubMed ID: 1417069 [TBL] [Abstract][Full Text] [Related]
20. Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A. Schopf RE; Hultsch T; Lotz J; Bräutigam M J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):234-9. PubMed ID: 9883435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]